Lipocine Inc.

LPCN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001535955

SEC filings (opens in a new tab)

In the last 90 days, Lipocine Inc. insiders filed 1 open-market purchase and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Lipocine Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of LPCN: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	21	19	−2
Shares	499.9K	483.9K	−16.0K (−3.2%)
Value	$1.48M	$1.35M	−$139.3K (−9.4%)

New holders (1)

Institutions that held Lipocine Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to LPCN in Q4 2023
Institution	Shares	Value	% of portfolio
Tidemark, LLC	59	$165	0.00%

Sold out (3)

Institutions that held Lipocine Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of LPCN in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Kestra Advisory Services, LLC	16,703	$49.8K
Cutler Group LP	765	$2.00K
UBS Group AG	42	$125